4.6 Article

Low-Salt Diet Reduces Anti-CTLA4 Mediated Systemic Immune-Related Adverse Events while Retaining Therapeutic Efficacy against Breast Cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Immune checkpoint inhibitors: Key trials and an emerging role in breast cancer

Nicola Gaynor et al.

Summary: This article reviews the use of immune checkpoint inhibitors as immunomodulatory agents for relieving immune suppression caused by tumors. These inhibitors have shown impressive results in various solid cancers, especially melanoma and non-small cell lung cancer. They have potential benefits for most cancer types and numerous clinical studies are being conducted to explore their efficacy. The article provides an overview of key clinical trials involving immune checkpoint inhibitors targeting PD-1, PD-L1, and CTLA-4, and discusses emerging therapies targeting these checkpoints as well as the status of immune checkpoint inhibitors in breast cancer.

SEMINARS IN CANCER BIOLOGY (2022)

Review Oncology

Immune-checkpoint inhibitors: long-term implications of toxicity

Douglas B. Johnson et al.

Summary: Immune-checkpoint inhibitors have improved outcomes for advanced-stage solid tumour patients, but they also carry the risk of chronic toxicities that can affect patients' quality of life. While evidence on chronic toxicities is limited, emerging evidence suggests that they may be more common than previously thought. These toxicities can affect various organ systems and may even lead to fatal outcomes. Research on the effects of immune-checkpoint blockade on other immune processes is also important for cancer survivors.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

Editorial Material Multidisciplinary Sciences

Immune-related adverse events and the balancing act of immunotherapy COMMENT

Michael Conroy et al.

Summary: The use of immune checkpoint inhibitors comes with immunologic toxicities that affect various organs and have different biology, onset time, and severity.

NATURE COMMUNICATIONS (2022)

Article Biotechnology & Applied Microbiology

Integrative Modeling of Multiomics Data for Predicting Tumor Mutation Burden in Patients with Lung Cancer

Jun Wang et al.

Summary: This study developed a prognostic model for predicting tumor mutation burden (TMB) by integrating multiomics data in patients with lung adenocarcinoma (LUAD), demonstrating good predictive performance and a significant correlation with TMB.

BIOMED RESEARCH INTERNATIONAL (2022)

Article Oncology

Tumor mutation burden for predicting immune checkpoint blockade response: the more, the better

Ming Zheng

Summary: This study aims to find the appropriate TMB cut-off values for different cancer types in predicting the efficacy of ICB treatment. The results show that the TMB cut-off values vary across different cancer types. Only in cancer types with high TMB, such as melanoma, colorectal cancer, bladder cancer, and non-small cell lung cancer, the association between TMB-H and ICB treatment outcomes is not affected by the selection of TMB cut-off values. Moreover, the high TMB cancer types share a range of TMB cut-off values, with a universally optimal TMB cut-off of 13 mut/Mb for predicting favorable ICB outcomes. In contrast, low TMB cancer types show sensitivity to the selection of TMB cut-off values and have limited and distinct ranges of significantly favorable TMB cut-off values. These findings suggest that TMB-H is more robustly associated with favorable ICB treatment outcomes in cancer types with higher TMBs.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Article Oncology

Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast Cancer

Abirami Sivapiragasam et al.

Summary: In this study, a large dataset of female metastatic breast cancers was analyzed using comprehensive genomic profiling to identify potential biomarkers associated with immunotherapy responsiveness. The study found various markers such as CD274 amplification, TMB, and MSI that may indicate response to immune checkpoint inhibitors in MBC. Furthermore, CGP shows promise in identifying genomic alterations linked to response and resistance to ICPI in MBC.

CANCER MEDICINE (2021)

Review Immunology

NLRP3 inflammasome in cancer and metabolic diseases

Bhesh Raj Sharma et al.

Summary: The NLRP3 inflammasome plays diverse roles in cancer and metabolic diseases, being involved in the release of inflammatory cytokines and inflammatory cell death upon activation. While inflammatory cytokines contribute to chronic inflammation and disease pathogenesis, fine tuning NLRP3 activity is crucial for maintaining cellular health.

NATURE IMMUNOLOGY (2021)

Article Oncology

Immune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not?

Heidar J. Albandar et al.

Summary: This study did not identify significantly different survival outcomes among the Appalachian West Virginia adult cancer patients treated with ICI who developed irAE and had treatment reinitiated after interruption, when compared with those not reinitiated.

CANCERS (2021)

Review Oncology

Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects

Remy Thomas et al.

Summary: Immunotherapy, particularly immune checkpoint inhibitors, has revolutionized cancer treatment by leveraging a patient's own immune system to combat tumors. Triple negative breast cancer, as an immunogenic subtype, shows potential for positive responses to immunotherapy. Exploration of tumor characteristics and treatment strategies is crucial for enhancing the efficacy of immune checkpoint blockade in breast cancer treatment.

FRONTIERS IN ONCOLOGY (2021)

Review Oncology

Adverse Events Following Administration of Anti-CTLA4 Antibody Ipilimumab

Amirali Karimi et al.

Summary: Ipilimumab, a monoclonal anti-CTLA4 antibody, has shown promising results in treating various cancers, particularly melanoma. However, its use may lead to autoimmune complications, highlighting the importance of recognizing and managing adverse events. Despite some non-melanoma cancers not having FDA approval yet, Ipilimumab has demonstrated effectiveness in this group as well.

FRONTIERS IN ONCOLOGY (2021)

Review Nutrition & Dietetics

Dietary Salt Intake and Gastric Cancer Risk: A Systematic Review and Meta-Analysis

Bo Wu et al.

Summary: High intakes of salt, pickled food, and processed meat are significantly associated with increased risks of gastric cancer, even when moderate amounts of salt are consumed.

FRONTIERS IN NUTRITION (2021)

Article Multidisciplinary Sciences

High-salt diet suppresses autoimmune demyelination by regulating the blood-brain barrier permeability

Shin-Young Na et al.

Summary: High salt consumption may suppress the development of central nervous system autoimmune diseases by increasing corticosterone levels, promoting the reinforcement of the blood-brain barrier, and controlling the entry of inflammatory T cells into the CNS.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Oncology

Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-risk Resected Melanoma

J. Randall Patrinely et al.

Summary: This multicenter cohort study found that chronic immune-related adverse events (irAEs) associated with anti-PD-1 therapy were more common than previously recognized, with a considerable proportion of patients developing chronic irAEs such as endocrinopathies and arthritis. Visceral organ-related irAEs had lower rates of becoming chronic, highlighting the importance of considering the risks of chronic irAEs in treatment decision-making.

JAMA ONCOLOGY (2021)

Article Oncology

Ex Vivo High Salt Activated Tumor-Primed CD4+T Lymphocytes Exert a Potent Anti-Cancer Response

Venkataswarup Tiriveedhi et al.

Summary: Cell based immunotherapy is showing promise in cancer treatment, and salt treatment has been found to induce anti-cancer response in immune cells, which could potentially be applied in future human clinical settings.

CANCERS (2021)

Article Oncology

Original Research Hyperacute toxicity with combination ipilimumab and anti-PD1 immunotherapy

Helen Dearden et al.

Summary: Combination ipilimumab and nivolumab therapy for metastatic melanoma patients may lead to hyperacute toxicity, requiring varying degrees of immunosuppression; some patients may require prolonged immunosuppression and remain at risk of further severe toxicity. The outcomes of such patients appear to be similar to those of trial populations.

EUROPEAN JOURNAL OF CANCER (2021)

Article Multidisciplinary Sciences

High-salt diet mediates interplay between NK cells and gut microbiota to induce potent tumor immunity

Zaigham Abbas Rizvi et al.

Summary: High-salt diet modulates tumor immunity by regulating gut microbiome, inducing NK cell-dependent immune response that inhibits tumor growth.

SCIENCE ADVANCES (2021)

Article Oncology

Frequency, Treatment and Outcome of Immune-Related Toxicities in Patients with Immune-Checkpoint Inhibitors for Advanced Melanoma: Results from an Institutional Database Analysis

Florentia Dimitriou et al.

Summary: This study investigated the impact of immune-related adverse events (irAEs) on the survival of advanced melanoma patients treated with immune-checkpoint inhibitors, finding that irAEs are correlated with treatment efficacy and may serve as potential prognostic markers in a non-adjuvant setting. Treatment with immunomodulatory agents did not affect the efficacy of immune checkpoint inhibitors, and patients with underlying autoimmune conditions may experience disease exacerbation.

CANCERS (2021)

Article Cell Biology

Cancer Salt Nostalgia

Aashish S. Allu et al.

Summary: High-salt diets are closely associated with disease states and poor health outcomes, impacting not only cardiovascular diseases, hypertension, and renal diseases, but also autoimmune diseases. Salt has been shown to modulate inflammatory activation of immune cells, leading to chronic inflammation-related diseases, with minimal evidence of direct correlation with cancer incidence and adverse clinical outcomes.
Review Cell Biology

NLRP3 Inflammasome and Inflammatory Diseases

Zheng Wang et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)

Review Immunology

NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword

Shaima'a Hamarsheh et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

A decade of immune-checkpoint inhibitors in cancer therapy

Caroline Robert

NATURE COMMUNICATIONS (2020)

Article Cardiac & Cardiovascular Systems

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary

Donna K. Arnett et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Review Oncology

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

Filipe Martins et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Review Immunology

Inflammation and Cancer: Triggers, Mechanisms, and Consequences

Florian R. Greten et al.

IMMUNITY (2019)

Review Biochemistry & Molecular Biology

The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation

Nathan Kelley et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Immunology

High Salt Inhibits Tumor Growth by Enhancing Anti-tumor Immunity

Ralf Willebrand et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Rheumatology

Toxicities associated with checkpoint inhibitors-an overview

Laura Spiers et al.

RHEUMATOLOGY (2019)

Review Nutrition & Dietetics

Sodium Intake and Hypertension

Andrea Grillo et al.

NUTRIENTS (2019)

Review Immunology

The NLRP3 inflammasome: molecular activation and regulation to therapeutics

Karen V. Swanson et al.

NATURE REVIEWS IMMUNOLOGY (2019)

Article Oncology

Potential anticancer effect of prostratin through SIK3 inhibition

Dalal Alotaibi et al.

ONCOLOGY LETTERS (2018)

Review Cardiac & Cardiovascular Systems

Role of salt intake in prevention of cardiovascular disease: controversies and challenges

Feng J. He et al.

NATURE REVIEWS CARDIOLOGY (2018)

Review Biochemistry & Molecular Biology

Role of the NLRP3 inflammasome in cancer

Maryam Moossavi et al.

MOLECULAR CANCER (2018)

Review Oncology

Inflammatory role of high salt level in tumor microenvironment

Suneetha Amara et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2017)

Article Multidisciplinary Sciences

Salt-responsive gut commensal modulates TH17 axis and disease

Nicola Wilck et al.

NATURE (2017)

Review Oncology

CTLA-4 and PD-1 Pathways Similarities, Differences, and Implications of Their Inhibition

Elizabeth I. Buchbinder et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2016)

Article Biochemistry & Molecular Biology

Oleanolic Acid Inhibits High Salt-Induced Exaggeration of Warburg-like Metabolism in Breast Cancer Cells

Suneetha Amara et al.

CELL BIOCHEMISTRY AND BIOPHYSICS (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Multiparametric MR Imaging of Breast Cancer

Habib Rahbar et al.

MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA (2016)

Article Medicine, Research & Experimental

Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells

Amanda L. Hernandez et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Article Immunology

High Dietary Salt Intake Exacerbates Helicobacter pylori-Induced Gastric Carcinogenesis

Jennifer A. Gaddy et al.

INFECTION AND IMMUNITY (2013)

Article Medicine, Research & Experimental

Immune cells control skin lymphatic electrolyte homeostasis and blood pressure

Helge Wiig et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Article Multidisciplinary Sciences

Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1

Chuan Wu et al.

NATURE (2013)

Article Multidisciplinary Sciences

NFAT5 induction by the pre-T-cell receptor serves as a selective survival signal in T-lymphocyte development

Rosa Berga-Bolanos et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Oncology

Mouse Models of Gastric Cancer

Yoku Hayakawa et al.

Cancers (2013)

Article Oncology

Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive 23Na MRI

Ronald Ouwerkerk et al.

BREAST CANCER RESEARCH AND TREATMENT (2007)

Article Multidisciplinary Sciences

NFAT5/TonEBP mutant mice define osmotic stress as a critical feature of the lymphoid microenvironment

WY Go et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)